Exogenous calreticulin improves diabetic wound healing

Wound Repair and Regeneration

Volumn 20, Issue 5, 2012, Pages 715-730

  Greives, Matthew R ^a,c   Samra, Fares ^a   Pavlides, Savvas C ^a   Blechman, Keith M ^a   Naylor, Sara Megumi ^a   Woodrell, Christopher D ^a   Cadacio, Caprice ^a   Levine, Jamie P ^a   Bancroft, Tara A ^a   Michalak, Marek ^b   Warren, Stephen M ^a   Gold, Leslie I ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; COLLAGEN; GLUCOSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHRONIC WOUND; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; EPITHELIAL GAP; EPITHELIZATION; FEMALE; FIBROBLAST; GRANULATION TISSUE; HAIR FOLLICLE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL; SKIN FIBROBLAST; SKINFOLD THICKNESS; WOUND CLOSURE; WOUND HEALING;

ANIMALS; CALRETICULIN; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; GRANULATION TISSUE; HUMANS; MACROPHAGES; MICE; MICE, INBRED NOD; WOUND HEALING;

EID: 84866490907     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00822.x     Document Type: Article

References (50)

1. Clark RA, Ghosh K, Tonnesen MG,. Tissue engineering for cutaneous wounds. J Invest Dermatol 2007; 127: 1018-1029.
2. Brem H, Sheehan P, Boulton AJ,. Protocol for treatment of diabetic foot ulcers. Am J Surg 2004; 187: 1S-10S.
3. Sweitzer SM, Fann SA, Borg TK, Baynes JW, Yost MJ,. What is the future of diabetic wound care? Diabetes Educ 2006; 32: 197-210.
4. Liu ZJ, Velazquez OC,. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008; 10: 1869-1882.
5. Singer AJ, Clark RA,. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
6. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Hoiby N, Givskov M,. Why chronic wounds will not heal: a novel hypothesis. Wound Rep Reg 2008; 16: 2-10.
7. Ochoa O, Torres FM, Shireman PK,. Chemokines and diabetic wound healing. Vascular 2007; 15: 350-355.
8. Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M,. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 2009; 417: 651-666.
9. Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM, Michalak M, Murphy-Ullrich JE,. Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J 2010; 24: 665-683.
10. Nanney LB, Woodrell CD, Greives MR, Cardwell NL, Pollins AC, Bancroft TA, Chesser A, Michalak M, Rahman M, Siebert JW, Gold LI,. Calreticulin enhances porcine wound repair by diverse biological effects. Am J Pathol 2008; 173: 610-630.
11. Sweetwyne MT, Pallero MA, Lu A, Van Duyn Graham L, Murphy-Ullrich JE,. The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling. Am J Pathol 2010; 177: 1710-1724.
12. Van Duyn Graham L, Sweetwyne MT, Pallero MA, Murphy-Ullrich JE,. Intracellular calreticulin regulates multiple steps in fibrillar collagen expression, trafficking, and processing into the extracellular matrix. J Biol Chem 2010; 285: 7067-7078.
13. Bedard K, Szabo E, Michalak M, Opas M,. Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int Rev Cytol 2005; 245: 91-121.
14. Szewczenko-Pawlikowski M, Dziak E, McLaren MJ, Michalak M, Opas M,. Heat shock-regulated expression of calreticulin in retinal pigment epithelium. Mol Cell Biochem 1997; 177: 145-152.
15. Waser M, Mesaeli N, Spencer C, Michalak M,. Regulation of calreticulin gene expression by calcium. J Cell Biol 1997; 138: 547-557.
16. Elton CM, Smethurst PA, Eggleton P, Farndale RW,. Physical and functional interaction between cell-surface calreticulin and the collagen receptors integrin alpha2beta1 and glycoprotein VI in human platelets. Thromb Haemost 2002; 88: 648-654.
17. McDonnell JM, Jones GE, White TK, Tanzer ML,. Calreticulin binding affinity for glycosylated laminin. J Biol Chem 1996; 271: 7891-7894.
18. Goicoechea S, Orr AW, Pallero MA, Eggleton P, Murphy-Ullrich JE,. Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin. J Biol Chem 2000; 275: 36358-36368.
19. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Michalak M, Henson PM,. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005; 123: 321-334.
20. Chao MP, Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, Volkmer J, Weiskopf K, Willingham SB, Raveh T, Park CY, Majeti R, Weissman IL,. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med 2010; 2: 63ra94.
21. Brem H, Tomic-Canic M,. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117: 1219-1222.
22. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC,. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003; 162: 303-312.
23. Hehenberger K, Heilborn JD, Brismar K, Hansson A,. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Rep Reg 1998; 6: 135-141.
24. Conway EM, Liu L, Nowakowski B, Steiner-Mosonyi M, Ribeiro SP, Michalak M,. Heat shock-sensitive expression of calreticulin. In vitro and in vivo up-regulation. J Biol Chem 1995; 270: 17011-17016.
25. Michaels JT, Dobryansky M, Galiano RD, Bhatt KA, Ashinoff R, Ceradini DJ, Gurtner GC,. Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor administration. Wound Rep Reg 2005; 13: 506-512.
26. Galiano RD, Michaels J, Dobryansky M, Levine JP, Gurtner GC,. Quantitative and reproducible murine model of excisional wound healing. Wound Rep Reg 2004; 12: 485-492.
27. Qi W, Poronnik P, Young B, Jackson CJ, Field MJ, Pollock CA,. Human cortical fibroblast responses to high glucose and hypoxia. Nephron Physiol 2004; 96: 121-129.
28. Deveci M, Gilmont RR, Dunham WR, Mudge BP, Smith DJ, Marcelo CL,. Glutathione enhances fibroblast collagen contraction and protects keratinocytes from apoptosis in hyperglycaemic culture. Br J Dermatol 2005; 152: 217-224.
29. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA,. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007; 170: 1178-1191.
30. Boulton AJ, Meneses P, Ennis WJ,. Diabetic foot ulcers: a framework for prevention and care. Wound Rep Reg 1999; 7: 7-16.
31. Younes NA, Albsoul AM, Awad H,. Diabetic heel ulcers: a major risk factor for lower extremity amputation. Ostomy Wound Manage 2004; 50: 50-60.
32. Falanga V,. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366: 1736-1743.
33. Michaels J, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, Gurtner GC,. db/db Mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Rep Reg 2007; 15: 665-670.
34. Schmidt-Ullrich R, Paus R,. Molecular principles of hair follicle induction and morphogenesis. Bioessays 2005; 27: 247-261.
35. Ito M, Yang Z, Andl T, Cui C, Kim N, Millar SE, Cotsarelis G,. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 2007; 447: 316-320.
36. Fathke C, Wilson L, Shah K, Kim B, Hocking A, Moon R, Isik F,. Wnt signaling induces epithelial differentiation during cutaneous wound healing. BMC Cell Biol 2006; 7: 4.
37. Loot MA, Kenter SB, Au FL, van, Galen WJ, Middelkoop E, Bos JD, Mekkes JR,. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol 2002; 81: 153-160.
38. Hehenberger K, Kratz G, Hansson A, Brismar K,. Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J Dermatol Sci 1998; 16: 144-151.
39. Brem H, Golinko MS, Stojadinovic O, Kodra A, Diegelmann RF, Vukelic S, Entero H, Coppock DL, Tomic-Canic M,. Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF. J Transl Med 2008; 6: 75.
40. Tarr JM, Young PJ, Morse R, Shaw DJ, Haigh R, Petrov PG, Johnson SJ, Winyard PG, Eggleton P,. A mechanism of release of calreticulin from cells during apoptosis. J Mol Biol 2012; 401: 799-812.
41. Cheng CF, Fan J, Fedesco M, Guan S, Li Y, Bandyopadhyay B, Li Y, Bright AM, Yerushalmi D, Liang M, Chen M, Han YP, Woodley DT, Li W,. Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing. Mol Cell Biol 2008; 28: 3344-3358.
42. Straino S, Di Carlo A, Mangoni A, De Mori R, Guerra L, Maurelli R, Panacchia L, Di Campli C, Uccioli L, Biglioli P, Bianchi ME, Capogrossi MC, Germani A,. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 2008; 128: 1545-1553.
43. Scaffidi P, Misteli T, Bianchi ME,. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
44. Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS,. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006; 291: C1318-1325.
45. Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G,. Immunogenic cancer cell death: a key-lock paradigm. Curr Opin Immunol 2008; 20: 504-511.
46. Obeid M,. Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin-inducer peptides. Mol Cancer Ther 2009; 8: 2693-2707.
47. Orr AW, Elzie CA, Kucik DF, Murphy-Ullrich JE,. Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J Cell Sci 2003; 116 (Pt 14): 2917-2927.
48. Pallero MA, Elzie CA, Chen J, Mosher DF, Murphy-Ullrich JE,. Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. FASEB J 2008; 22: 3968-3979.
49. Coppolino MG, Dedhar S,. Ligand-specific, transient interaction between integrins and calreticulin during cell adhesion to extracellular matrix proteins is dependent upon phosphorylation/dephosphorylation events. Biochem J 1999; 340 (Pt 1): 41-50.
50. Papp S, Szabo E, Kim H, McCulloch CA, Opas M,. Kinase-dependent adhesion to fibronectin: regulation by calreticulin. Exp Cell Res 2008; 314: 1313-1326.